Montelukast May Induce Depression; Light Exposure May Increase Alzheimer's Disease Risk
Recently, the National Medical Products Administration issued an announcement (No. 120 of 2025) on revising the package inserts for montelukast preparations, requiring that warning language be added to the inserts of all montelukast formulations, alerting that montelukast carries a risk of inducing depression, self-harm, and…
Continue reading...